G. Thabut, P. Mordant, Y. Castier, and H. Mal, Transplantations pulmonaires, EMC- Pneumologie. oct, vol.12, issue.4, 2015.

. Agence-de-la-biomédecine, Le rapport médical et scientifique du prélèvement et de la greffe en France [Internet]. 2016 [cité 18 sept 2017] Disponible sur: www.agencebiomedecine .fr. 3. International Society for Heart and Lung Transplantation. Heart/Lung Registries ? Slides -Overall Lung Transplantation Statistics, p.2016

S. Quétant, T. Rochat, and C. Pison, R??sultats de la transplantation pulmonaire, Revue des Maladies Respiratoires, vol.27, issue.8, pp.921-959, 2010.
DOI : 10.1016/j.rmr.2010.08.001

M. Thompson, J. Flynn, and T. Clifford, Pharmacotherapy of Lung Transplantation, Journal of Pharmacy Practice, vol.9, issue.9, pp.5-13, 2013.
DOI : 10.1111/j.1600-6143.2009.02734.x

P. Halloran, Immunosuppressive Drugs for Kidney Transplantation, New England Journal of Medicine, vol.351, issue.26, pp.2715-2744, 2004.
DOI : 10.1056/NEJMra033540

C. Knoop, C. Rondelet, B. Dumonceaux, M. Estenne, M. Raghu et al., Complications non chirurgicales de la transplantation pulmonaire A new classification system for chronic lung allograft dysfunction, 127?33. 12. CHUGA -Procédure interne. Dysfonction chronique du greffon pulmonaire (CLAD), 2011.

G. Verleden, S. Verleden, R. Vos, D. Vleeschauwer, S. Dupont et al., Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study, 651?6. 15. CHUGA -Procédure interne. Prophylaxie antibiotique et antifongique en pergreffe pulmonaire, 2011.
DOI : 10.1016/j.jaci.2006.08.028

E. Schmitt, D. Antier, C. Bernheim, E. Dufay, M. Husson et al., Dictionnaire français de l'erreur médicamenteuse. 1ère édition : Société Française de Pharmacie Clinique, Disponible sur, 2006.

K. Abbott, R. Viola, and L. Agodoa, Hospitalized poisonings after renal transplantation in the United States, BMC Nephrology, vol.8, issue.4, p.10, 2002.
DOI : 10.7182/prtr.1.8.4.tl87qu8t5442856g

A. Friedman, S. Geoghegan, N. Sowers, S. Kulkarni, R. Formica et al., Medication Errors in the Outpatient Setting, 513?21. 23. SFPC. Standardisation et valorisation des activités de pharmacie clinique, 1960.
DOI : 10.1001/archsurg.142.3.278

O. Bedouch, P. Juste, M. Charpiat, B. Roubille, R. Juste et al., Disponible sur Validation of an instrument for the codification of clinical pharmacy interventions Site internet de la Société française de pharmacie clinique pour l'analyse des interventions pharmaceutiques : finalité, mode d'emploi et perspectives, J Pharm Clin. J Pharm Clin. 1 janv, vol.2326, issue.1, pp.40-44, 2004.

B. Allenet, P. Bedouch, F. Rose, L. Escofier, R. Roubille et al., Validation of an instrument for the documentation of clinical pharmacists Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP© website observatory, ):181?8. 27. Bedouch P,32?40. 28. Bates DW, Spell, pp.307-318, 1997.

T. Vo, C. Catoire, B. Charpiat, and P. Bedouch, Development and Validation of a multidimensional scale " CLEO " for evaluating potential significance of a pharmacist intervention, American College of Clinical Pharmacy Annual Meeting, 2014.

T. Vo, Evaluation of the potential impact of pharmacist interventions : development and validation of the CLEO multidimensional tool
URL : https://hal.archives-ouvertes.fr/tel-01315619

T. Vo, B. Charpiat, C. Catoire, M. Juste, R. Roubille et al., Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review, Drug Safety, vol.17, issue.6, pp.131-177, 2016.
DOI : 10.2165/00019053-200017060-00002

Z. Prina and C. , Impact clinique, économique et organisationnel des interventions pharmaceutiques lors de l'analyse des prescriptions d'anticancéreux injectables

J. Harrison, J. Wang, J. Cervenko, L. Jackson, D. Munyal et al., Pilot study of a pharmaceutical care intervention in an outpatient lung transplant clinic, Clinical Transplantation, vol.11, issue.2, pp.149-157, 2012.
DOI : 10.1111/j.1600-6143.2011.03601.x

C. Monchaud and P. Marquet, Pharmacokinetic Optimization of Immunosuppressive Therapy in Thoracic Transplantation: Part I, Clinical Pharmacokinetics, vol.30, issue.4, pp.419-62, 2009.
DOI : 10.1111/j.1365-2125.1992.tb05657.x

URL : https://hal.archives-ouvertes.fr/inserm-00326000

C. Monchaud, P. Marquet, M. Sikma, E. Van-maarseveen, E. Van-de-graaf et al., Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation, ):489?516. 36, pp.2301-2314, 2009.

J. Mitchell, Pharmacist involvement as a member of a renal transplant team, Am J Hosp Pharm. janv, vol.33, issue.1, pp.55-63, 1976.

G. Burckart, Transplant Pharmacy: 30 Years of Improving Patient Care, Annals of Pharmacotherapy, vol.58, issue.7-8, pp.1261-1264, 2007.
DOI : 10.2515/therapie:2003047

C. Musgrave, N. Pilch, D. Taber, H. Meadows, J. Mcgillicuddy et al., Improving Transplant Patient Safety Through Pharmacist Discharge Medication Reconciliation, American Journal of Transplantation, vol.15, issue.3, pp.796-801, 2013.
DOI : 10.1111/j.1365-2753.2008.01000.x

S. Asavakarn, Y. Sirivatanauksorn, R. Promraj, A. Ruenrom, S. Limsrichamrern et al., Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients [Evaluation of drug therapy knowledge in liver transplant patients after pharmacy counseling], 1202?7. 42. Monnier G, pp.305-316, 2003.

Y. Ah, J. Lee, M. Moon, Y. Cho, H. Kim et al., Clinical and economic evaluation of pharmacists' contribution to patient care on a multi-disciplinary liver transplant team Value of solid organ transplant-trained pharmacists in transplant infectious diseases, Int J Clin Pharmacol Ther. févr Curr Infect Dis Rep. avr, vol.5417, issue.24, p.475, 2015.

A. Maldonado, D. Weeks, A. Bitterman, J. Mccleary, T. Seiger et al., Changing transplant recipient education and inpatient transplant pharmacy practices: a single-center perspective. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, pp.900-904, 2013.

R. Joost, F. Dörje, J. Schwitulla, K. Eckardt, and C. Hugo, Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc):1597?607. 47. Guidelines for ATC classification and DDD assignment, 19th edition. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway; 2016. 48. Pareto chart -Six Sigma [Internet], août, vol.29, issue.8, 2014.

P. Firmino, Pharmaceutical orientation at hospital discharge of transplant patients: strategy for patient safety, Einstein Sao Paulo Braz. sept, vol.14, issue.3, pp.359-65, 2016.

H. Wang, A. Chan, M. Chen, C. Liao, Y. Tian et al., Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics):2319?23. 54. Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction, Transplant Proc. sept Basic Clin Pharmacol Toxicol. mars Drug Intell Clin Pharm. mars, vol.4010222, issue.733, pp.275-80, 1988.

J. Overhage and A. Lukes, Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities, Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 1 déc, vol.56, issue.23, pp.2444-50, 1999.

J. Gallagher, S. Mccarthy, and S. Byrne, Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature, International Journal of Clinical Pharmacy, vol.12, issue.3, pp.1101-1115, 2014.
DOI : 10.1111/j.1524-4733.2009.00516.x

M. Chisholm, L. Vollenweider, L. Mulloy, J. Wynn, W. Wade et al., Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic, Clinical Transplantation, vol.18, issue.4, pp.304-311, 2000.
DOI : 10.1016/S0025-7125(16)30616-2

M. Chisholm, L. Mulloy, M. Jagadeesan, and J. Dipiro, Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications, Clinical Transplantation, vol.20, issue.3, pp.330-336, 2001.
DOI : 10.1001/archinte.139.6.627

N. Partovi, W. Chan, and C. Nimmo, Evaluation of a patient education program for solid organ transplant patients, Can J Hosp Pharm. avr, vol.48, issue.2, pp.72-80, 1995.

A. Ciminelli, R. Dupuis, D. Williams, K. Hollar, J. Fair et al., Patient education role of a pharmacist on a transplant service Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 15 avr Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications, 767?8. 62. Tschida S, pp.26-41, 2000.

M. Zolezzi, The role of the clinical pharmacist in the care of renal transplant patients

N. Pilch, S. Patel, K. Trobaugh, J. Fleming, and H. Meadows, Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic, ):14?7. 64. Staino C, pp.613-633, 2002.

J. Hlubocky, L. Stuckey, A. Schuman, J. Stevenson, D. Taber et al., Evaluation of a transplantation specialty pharmacy program 15 févr 2012 Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients Impact of clinical pharmacy services on renal transplant recipients' adherence and outcomesPharmaceutical consultation for liver transplant patients: a contribution to therapeutic education Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring Roles of Pharmacist as a Member of the Liver Transplant team in Controlling Tacrolimus whole Blood Concentrations and Monitoring Adverse Drug Events such as Convulsion Survey of transplant-related pharmacy services at large comprehensive transplant centers in the United States Prog Transplant Aliso Viejo Calif, 41?53. 69. Klein A, pp.103-12393, 2002.

D. Taber, N. Pilch, J. Trofe-clark, and T. Kaiser, A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant Programs, American Journal of Transplantation, vol.29, issue.10, pp.2683-90, 2015.
DOI : 10.1093/ndt/gfu207

R. Alloway, R. Dupuis, S. Gabardi, T. Kaiser, D. Taber et al., Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantation United Network for Organ Sharing Attachment 1 to Appendix B of UNOS Bylaws: Designated Transplant Program criteria, août Clin Transplant, vol.1118, issue.74, 2004.

L. Angleviel, Intégration des technologies de l'information et des communications dans un programme d'éducation thérapeutique des patients en transplantation pulmonaire : application mobile, pp.58-64